Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
@home Lybrido/Lybridos in female sexual dysfunction
NL-OMON28613Active, not recruiting
- Sponsor
- Emotional Brain
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sildenafil + testosterone and Lybridos in female sexual dysfunction (FSD), hypoactive sexual desire disorder (HSDD) and Sexual Arousal Disorder (4 arms), sponsored by Emotional Brain. Primary endpoint: Primary efficacy endpoint. Started Feb 2008; status: active, not recruiting.
02
Drugs
sildenafil + testosteroneLybridos
03
Conditions
female sexual dysfunction (FSD)hypoactive sexual desire disorder (HSDD)Sexual Arousal Disorder
Beyond the preview
Go deeper on NL-OMON28613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28613.